No profile data available.
Aclarion, Inc. (ACON) is a healthcare company in the medical sector application systems industry, based in Broomfield, United States, with about 10 full-time employees.
It reported revenue of $45,724 for fiscal year 2024, down 39.4% from fiscal year 2023, and net income of -$7.05 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $18,942, up 31.5% from a year before. United States was its largest region in fiscal year 2024, with 65% of revenue. Its market capitalization was $6.74 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine.
Aclarion reported $45,724 in revenue for fiscal year 2024, down 39.4% from $75,404 in fiscal year 2023. In Q3 2025 revenue was $18,942.
United States: 65% of revenue by region in fiscal year 2024, followed by outside The United States (35%).
$6.74 million as of October 9, 2026.
Listed companies of a similar size in the same industry (medical sector application systems) include Bullfrog AI Holdings, Inc. (BFRG), Datatrak International, Inc. (DTRK), Healthcare Triangle, Inc. (HCTI), nDatalyze Corp. (NDATF).